Other Species / Isoforms
  TRPV1 (rat)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
A5
___MEQRAsLDSEES
0 1
TRPV1 (human) ___MKKWsstDLGAA S5-p
TRPV1 (mouse) ___MEKWASLDSDES A5
TRPV1 (rat) ___MEQRAsLDSEES A5
S6-p
__MEQRAsLDSEESE
Upstream
1 1
Kinase, in vitro:
  • PKACA (cow)
TRPV1 (human) __MKKWsstDLGAAA S6-p
TRPV1 (mouse) __MEKWASLDSDESE S6
TRPV1 (rat) __MEQRAsLDSEESE S6-p
L7
_MEQRAsLDSEESES
0 1
TRPV1 (human) _MKKWsstDLGAAAD T7-p
TRPV1 (mouse) _MEKWASLDSDESEP L7
TRPV1 (rat) _MEQRAsLDSEESES L7
S116-p
PRLYDRRsIFDAVAQ
Upstream
Downstream
6 1
Effects on Modified Protein
  • receptor desensitization, altered
Kinase, in vitro:
  • PKACA (cow)
  • PRKD1 (rat)
Putative in vivo kinases:
  • PKACA (cow)
Treatment
  • 8-Br-AMP
  • H-89
TRPV1 (human) LRLYDRRsIFEAVAQ S117-p
TRPV1 (mouse) PRLYDRRSIFDAVAQ S117
TRPV1 (rat) PRLYDRRsIFDAVAQ S116-p
S131
SNCQELESLLPFLQR
0 2
TRPV1 (human) NNCQDLEsLLLFLQK S132-p
TRPV1 (mouse) SNCQELESLLSFLQK S132
TRPV1 (rat) SNCQELESLLPFLQR S131
S139
LLPFLQRSKKRLtDS
0 1
TRPV1 (human) LLLFLQKsKKHLTDN S140-p
TRPV1 (mouse) LLSFLQKSKKRLtDS S140
TRPV1 (rat) LLPFLQRSKKRLtDS S139
T144-p
QRSKKRLtDSEFKDP
Upstream
5 0
Kinase, in vitro:
  • PKACA (cow)
  • PKCA (human)
TRPV1 (human) QKsKKHLTDNEFKDP T145
TRPV1 (mouse) QKSKKRLtDSEFKDP T145-p
TRPV1 (rat) QRSKKRLtDSEFKDP T144-p
K160
TGKTCLLKAMLNLHN
0 1
TRPV1 (human) TGKTCLLkAMLNLHD K161-ac
TRPV1 (mouse) TGKTCLLKAMLNLHN K161
TRPV1 (rat) TGKTCLLKAMLNLHN K160
T195
QFVNASYTDSYyKGQ
0 1
TRPV1 (human) ELVNASYtDSYyKGQ T196-p
TRPV1 (mouse) QFVNASYTDSYYKGQ T196
TRPV1 (rat) QFVNASYTDSYyKGQ T195
Y199-p
ASYTDSYyKGQTALH
Downstream
2 0
Effects on Modified Protein
  • activity, induced
TRPV1 (human) ASYtDSYyKGQTALH Y200-p
TRPV1 (mouse) ASYTDSYYKGQTALH Y200
TRPV1 (rat) ASYTDSYyKGQTALH Y199-p
K265
TNQLAIVKFLLQNSW
0 1
TRPV1 (human) TNQLGIVKFLLQNSW K266
TRPV1 (mouse) TNQLAIVkFLLQNSW K266-ac
TRPV1 (rat) TNQLAIVKFLLQNSW K265
T329
TLKLEEITNRKGLTP
0 1
TRPV1 (human) TLKLEELTNKKGMtP T330
TRPV1 (mouse) TLKLEELtNKKGLTP T330-p
TRPV1 (rat) TLKLEEITNRKGLTP T329
T335
ITNRKGLTPLALAAS
0 1
TRPV1 (human) LTNKKGMtPLALAAG T336-p
TRPV1 (mouse) LtNKKGLTPLALAAS T336
TRPV1 (rat) ITNRKGLTPLALAAS T335
T370-p
RHLSRKFtEWAYGPV
Upstream
Downstream
4 0
Effects on Modified Protein
  • molecular association, regulation
  • receptor desensitization, altered
Kinase, in vitro:
  • PKACA (cow)
Putative in vivo kinases:
  • PKACA (cow)
Treatment
  • 8-Br-AMP
  • H-89
TRPV1 (human) RHLSRKFTEWAYGPV T371
TRPV1 (mouse) RHLSRKFtEWAYGPV T371-p
TRPV1 (rat) RHLSRKFtEWAYGPV T370-p
T406-p
IAYSSSEtPNRHDML
Upstream
Downstream
5 0
Effects on Modified Protein
  • activity, inhibited
  • intracellular localization
  • molecular association, regulation
  • phosphorylation
  • protein conformation
  • receptor desensitization, inhibited
Kinase, in vitro:
  • CDK5 (rat)
Putative in vivo kinases:
  • CDK5 (rat)
Treatment
  • peptide inhibitor
  • seliciclib
TRPV1 (human) IAYSSSETPNRHDML T407
TRPV1 (mouse) IAYSSSEtPNRHDML T407-p
TRPV1 (rat) IAYSSSEtPNRHDML T406-p
S502-p
YFLQRRPsLKSLFVD
Upstream
Downstream
20 0
Effects on Modified Protein
  • activity, induced
  • receptor desensitization, altered
  • receptor desensitization, inhibited
Kinase, in vitro:
  • PKACA (cow)
  • PKCA (human)
  • PKCE (rat)
Putative in vivo kinases:
  • CAMK2A (human)
  • PKCA (human)
  • PKCA (rat)
  • PKCE (no information)
Treatment
  • bisindolylmaleimide
  • calphostin_C
  • capsaicin
  • endothelin
  • epsilonV1-2
  • Go_6976
  • Ki16425
  • LPA
  • phorbol_ester
TRPV1 (human) YFLQRRPsMKTLFVD S502-p
TRPV1 (mouse) YFLQRRPSLKSLFVD S503
TRPV1 (rat) YFLQRRPsLKSLFVD S502-p
T704-p
WKLQRAItILDTEKS
Upstream
Downstream
6 0
Effects on Modified Protein
  • activity, induced
  • receptor desensitization, altered
Kinase, in vitro:
  • PKCA (human)
Putative in vivo kinases:
  • CAMK2A (human)
  • PKCE (no information)
Treatment
  • epsilonV1-2
  • Ki16425
  • LPA
TRPV1 (human) WKLQRAItILDTEKS T705-p
TRPV1 (mouse) WKLQRAITILDTEKS T705
TRPV1 (rat) WKLQRAItILDTEKS T704-p
T772
NCEGVKRTLsFSLRS
0 2
TRPV1 (human) NCEGVKRtLsFSLRs T773-p
TRPV1 (mouse) NCEGVKRTLSFSLRS T773
TRPV1 (rat) NCEGVKRTLsFSLRS T772
S774-p
EGVKRTLsFSLRSGR
Upstream
3 1
Kinase, in vitro:
  • PKACA (cow)
  • PKCA (human)
TRPV1 (human) EGVKRtLsFSLRsSR S775-p
TRPV1 (mouse) EGVKRTLSFSLRSGR S775
TRPV1 (rat) EGVKRTLsFSLRSGR S774-p
S779
TLsFSLRSGRVSGRN
0 1
TRPV1 (human) tLsFSLRsSRVSGRH S780-p
TRPV1 (mouse) TLSFSLRSGRVSGRN S780
TRPV1 (rat) TLsFSLRSGRVSGRN S779
S800-p
VPLLRDAsTRDRHAT
Upstream
Downstream
23 0
Effects on Modified Protein
  • activity, induced
  • molecular association, regulation
  • receptor desensitization, altered
  • receptor desensitization, inhibited
Effects on Biological Processes:
  • cytoskeletal reorganization
Kinase, in vitro:
  • PKCA (human)
  • PKCE (rat)
Putative in vivo kinases:
  • PKCA (human)
  • PKCA (rat)
  • PKCE (rat)
Regulatory protein:
  • AKAP5 (rat)
  • SUMO1 (human)
Treatment
  • bisindolylmaleimide
  • calphostin_C
  • capsaicin
  • DHPG
  • endothelin
  • estradiol
  • GF109203X
  • Go_6976
  • mono-iodoacetate (MIA)-induced joint pain model
  • NMDA
  • phorbol_ester
TRPV1 (human) VPLLREAsARDRQsA S801-p
TRPV1 (mouse) VPLLRDAsTRDRHST S801-p
TRPV1 (rat) VPLLRDAsTRDRHAT S800-p
A806
AsTRDRHATQQEEVQ
0 1
TRPV1 (human) AsARDRQsAQPEEVy S807-p
TRPV1 (mouse) AsTRDRHSTQPEEVQ S807
TRPV1 (rat) AsTRDRHATQQEEVQ A806
Q813
ATQQEEVQLKHYTGs
0 1
TRPV1 (human) sAQPEEVyLRQFSGS Y814-p
TRPV1 (mouse) STQPEEVQLKHYTGS Q814
TRPV1 (rat) ATQQEEVQLKHYTGs Q813
S820-p
QLKHYTGsLkPEDAE
Upstream
2 0
Kinase, in vitro:
  • PKACA (cow)
  • PKCA (human)
TRPV1 (human) yLRQFSGSLKPEDAE S821
TRPV1 (mouse) QLKHYTGSLkPEDAE S821
TRPV1 (rat) QLKHYTGsLkPEDAE S820-p
K822-sm
KHYTGsLkPEDAEVF
Downstream
1 0
Effects on Modified Protein
  • phosphorylation
TRPV1 (human) RQFSGSLKPEDAEVF K823
TRPV1 (mouse) KHYTGSLkPEDAEVF K823-sm
TRPV1 (rat) KHYTGsLkPEDAEVF K822-sm